Yes, Rogues, a very good summary of progress, which continues to...

Yes, Rogues, a very good summary of progress, which continues to encourage. Just a couple of brief observations:

Slide 5 (with the ticked orange and blue circles) - compare these with page 8 of the presentation of August 7th last year, just 7 months back, when they were noted as objectives in the commercialisation pathway. Very good progress. (Medtech is well on the back burner for the moment.)

When I first scanned the announcement, I thought, "well, there's nothing very new here", but then realised that the very first slide after the quick summary is the corporate snapshot. "Aha, this is aimed clearly at institutional and/or cornerstone investors, and has already been presented to them". As a good update, and perhaps as part of ASX reporting, it is now released.

Last observation: the forecasts of market sizes indicates that MS has been doing his usual research.